Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Temporal triangular alopecia in infants is mostly seen in males at birth, with unique features that help with diagnosis.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Terminalia bellirica extract may help promote hair growth and prevent hair loss caused by testosterone.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Baricitinib can cause excessive hair growth.

A 3-year-old boy was diagnosed with a rare, non-scarring hair loss condition called temporal triangular alopecia.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

CTP-543 is generally safe for treating alopecia areata.

Biotin and biotinidase are essential to prevent health issues, and deficiencies require lifelong supplementation.

Teprotumumab for thyroid eye disease commonly causes fatigue, brittle nails, dry eyes, hair loss, muscle spasms, and dry mouth, with rare serious events like blood clots.

Baricitinib was effective in treating both early and late onset alopecia areata.

An 8-year-old boy with hair-pulling disorder had a bald patch that was confirmed not to be a fungal infection and was treated with therapy.

Early diagnosis, genetic testing, and personalized care are essential for managing tuberous sclerosis.

Telocytes have potential in therapy and tissue regeneration, but challenges in identification and cultivation remain.

Adults with Tatton-Brown-Rahman syndrome may have serious heart problems and need lifelong heart monitoring.

Baricitinib helps regrow hair in teens with severe alopecia areata.

The right dosage of CPA and TB can work as a safe and reversible male contraceptive in monkeys.

Most patients with Tuberous sclerosis had neurological or skin issues, and over half had psychiatric problems.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

TDM10842, a thyroid hormone receptor activator, was found to effectively promote hair growth in mice.